BioCentury | Nov 27, 2019
Company News

Nov. 27 Company Quick Takes: Orexo, GAIA in second deal for substance abuse digital therapy; plus PDUFA date for Verrica's skin infection candidate and $25M fol

...companies to develop a psychosocial support product intended to enhance the use of Orexo's Zubsolv buprenorphine/naloxone...
BioCentury | Aug 21, 2019
Company News

Orexo, GAIA to develop digital therapeutic for opioid use disorder

...GAIA, Orexo will develop a psychosocial support product intended to enhance the use of Zubsolv buprenorphine/naloxone...
...be used in concert with addiction therapies such as naloxone and methadone. Paul Bonanos, Associate Editor Zubsolv, buprenorphine/naloxone...
BioCentury | Apr 12, 2019
Product Development

Changing models and minds to improve access to addiction treatment

...has led some to only accept cash payments for some therapies, such as Orexo’s Zubsolv buprenorphine/naloxone...
BioCentury | Apr 10, 2019
Company News

U.S. fraud charges pummel Indivior shares

...and forfeit all of its assets, inventory and property, including 11 patents related to Suboxone buprenorphine/naloxone...
...Are Not Cost-Effective” ). Mary Romeo, Staff Writer Sublocade (Brand), RBP-6000 (Compound #), buprenorphine (Generic) Suboxone sublingual film, buprenorphine/naloxone Vivitrol...
BioCentury | Apr 5, 2019
Product Development

Reaching addiction patients where they’re at

...Department of Veterans Affairs (VA), Washington, D.C. Erin McCallister, Senior Editor Vivitrol, naltrexone (Medisorb naltrexone, Vivitrex, XR-NTX) Zubsolv, buprenorphine/naloxone...
BioCentury | Feb 22, 2019
Company News

Generic Suboxone products enter U.S. market

...least three companies have launched in the U.S. generic versions of opioid dependence drug Suboxone buprenorphine/naloxone...
...SIX:NOVN), Basel, Switzerland Dr. Reddy's Laboratories Ltd. (NYSE:RDY), Hyderabad, India Business: Neurology Shannon Lehnbeuter Suboxone sublingual film, buprenorphine/naloxone Alvogen...
BioCentury | Feb 15, 2019
Company News

Indivior divests Suboxone tablets to China’s Zhejiang Pukang

...Indivior plc (LSE:INDV) will sell Chinese rights to its sublingual tablet formulation of Suboxone buprenorphine/naloxone to...
...Indivior plc (LSE:INDV), Richmond, Va. Zhejiang Pukang Biotechnology Co. Ltd., Hangzhou, China Business: Neurology Hongjiang Li Suboxone, buprenorphine/naloxone Indivior...
BioCentury | Dec 21, 2018
Company News

Orexo regains ex-U.S. rights to Zubsolv from Mundipharma

...Orexo AB (SSE:ORX) will regain global, ex-U.S. rights to Zubsolv buprenorphine/naloxone from Mundipharma International Ltd. (Dublin...
...opioid dependence. Orexo AB (SSE:ORX), Uppsala, Sweden Mundipharma International Ltd., Dublin, Ireland Business: Neurology Shannon Lehnbeuter Zubsolv, buprenorphine/naloxone...
BioCentury | Nov 30, 2018
Company News

Dr. Reddy's gets green light to market opioid dependence generic

...court's preliminary decision that prohibited the company from selling its generic version of film Suboxone buprenorphine/naloxone...
...according to Dr. Reddy's. In June, FDA approved Dr. Reddy's product and a separate generic buprenorphine/naloxone...
...Laboratories Ltd. (NYSE:RDY), Hyderabad, India Indivior plc (LSE:INDV), Richmond, Va. Business: Generics Allison Johnson Suboxone sublingual film, buprenorphine/naloxone Dr...
BioCentury | Sep 14, 2018
Company News

ICER finds opioid use disorder treatments not cost-effective

...ranges. Despite its high cost-effectiveness ratio, ICER found Vivitrol's clinical effectiveness to be comparable to buprenorphine/naloxone...
Items per page:
1 - 10 of 122